Comparison of the Efficacy of Tolterodine versus Oxybutynin in the Treatment of Children with Desmopressin-Resistant Enuresis: A Randomized Controlled Clinical Trial
- PMID: 38784212
- PMCID: PMC11111179
- DOI: 10.4314/ejhs.v33i4.7
Comparison of the Efficacy of Tolterodine versus Oxybutynin in the Treatment of Children with Desmopressin-Resistant Enuresis: A Randomized Controlled Clinical Trial
Abstract
Background: Enuresis, defined as involuntary nocturnal urination without any underlying organic disorder in a child expected to control urination, poses a common problem. This study evaluated the effectiveness of Tolterodine and Oxybutynin in children presenting with primary desmopressin-resistant enuresis.
Materials and methods: A randomized clinical trial was undertaken involving 68 participants aged between 5 and 16 years, all suffering from primary enuresis. These patients were randomly assigned to one of two treatment groups for a three-month period: Group 1, treated with Oxybutynin and Desmopressin, and Group 2, treated with Tolterodine and Desmopressin. Data on demographics, clinical and laboratory findings, and subjective responses to treatment were gathered. The response was measured based on the frequency of wetting incidents per night and week and compared with pre-treatment data.
Results: Patients were divided into two groups (30 patients in Group 1 and 38 patients in Group 2). The mean age of the patients was 88.97±27.09 months. In the first treatment group, 6 out of 30 patients (20%) experienced a complete treatment response, as did 5 out of 38 patients (13.2%) in the second treatment group. This difference between the groups was not statistically significant. Seven patients (23%) in the Oxybutynin group and 13 patients (34%) in the Tolterodine group reported a lack of response to treatment, a difference that also lacked statistical significance.
Conclusion: For patients resistant to Desmopressin, the addition of anticholinergic drugs elicited a significant response in over half of the patients. However, no benefit was observed in using either Oxybutynin or Tolterodine in the treatment of Desmopressin-resistant enuresis.
Keywords: Desmopressin; Enuresis; Oxybutynin; Tolterodine.
© 2023 Neda E., et al.
Figures

Similar articles
-
Desmopressin and oxybutynin in monosymptomatic nocturnal enuresis: a randomized, double-blind, placebo-controlled trial and an assessment of predictive factors.BJU Int. 2012 Oct;110(8 Pt B):E381-6. doi: 10.1111/j.1464-410X.2011.10918.x. Epub 2012 Feb 7. BJU Int. 2012. PMID: 22313792 Clinical Trial.
-
Evaluating use of higher dose oxybutynin in combination with desmopressin for refractory nocturnal enuresis.J Pediatr Urol. 2016 Aug;12(4):220.e1-6. doi: 10.1016/j.jpurol.2016.05.029. Epub 2016 Jun 11. J Pediatr Urol. 2016. PMID: 27373215
-
Desmopressin versus desmopressin + oxybutynin in the treatment of children with nocturnal enuresis.J Pediatr Urol. 2021 Aug;17(4):451.e1-451.e6. doi: 10.1016/j.jpurol.2021.04.001. Epub 2021 Apr 8. J Pediatr Urol. 2021. PMID: 33931318
-
Therapeutic options in childhood nocturnal enuresis.Minerva Urol Nefrol. 2007 Jun;59(2):199-205. Minerva Urol Nefrol. 2007. PMID: 17571056 Review.
-
Comparison of desmopressin, alarm, desmopressin plus alarm, and desmopressin plus anticholinergic agents in the management of paediatric monosymptomatic nocturnal enuresis: a network meta-analysis.BJU Int. 2019 Mar;123(3):388-400. doi: 10.1111/bju.14539. Epub 2018 Oct 31. BJU Int. 2019. PMID: 30216627 Review.
Cited by
-
Pharmacological treatment of pediatric nocturnal enuresis: a systematic review and network meta-analysis.Pediatr Nephrol. 2025 Sep;40(9):2795-2806. doi: 10.1007/s00467-025-06783-5. Epub 2025 Apr 24. Pediatr Nephrol. 2025. PMID: 40272475
References
-
- Tsuji S. Criteria for nocturnal polyuria in nocturnal enuresis. Pediatr Int. 2021;63(11):1275–1276. - PubMed
-
- Taborga Díaz E, Martínez Suárez V, Alcántara-Canabal L, Suárez Castañón C, Cebrián Muíños C. Assessment of nocturnal enuresis diagnostic criteria. An Pediatr. (Engl Ed) 2021;95(2):101–107. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources